Connecting to SEC EDGAR… PricingSign in
← All filings

DSGN

Design Therapeutics, Inc. SEC filings
Pharmaceutical Preparations · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for DSGN right now.
Filing history
2026-11-04
Shelf registration (future share sales) S-3
Filing ↗
2026-11-04
Prospectus 424B5
Filing ↗
2026-11-04
Quarterly report 10-Q
Filing ↗
2026-11-04
Current report 8-K
Earnings results
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-14
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-08-03
Quarterly report 10-Q
Filing ↗
2026-08-03
Current report 8-K
Earnings results
Filing ↗
2026-06-11
Insider trade 4
Filing ↗
2026-06-11
Insider trade 4
Filing ↗
2026-06-11
Insider trade 4
Filing ↗
2026-06-11
Insider trade 4
Filing ↗
2026-06-11
Insider trade 4
Filing ↗
2026-06-11
Insider trade 4
Filing ↗
2026-06-11
Current report 8-K
Shareholder vote
Filing ↗
2026-06-09
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-05-18
Current report 8-K
Other event
Filing ↗
2026-05-15
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-04-28
Quarterly report 10-Q
Filing ↗
2026-04-28
Current report 8-K
Earnings resultsReg FD disclosure
Filing ↗
2026-04-23
Proxy material DEFA14A
Filing ↗
2026-04-23
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-04-23
Annual report to shareholders ARS
Filing ↗
2026-04-01
Insider trade 4
Filing ↗
2026-04-01
New insider's holdings 3
Filing ↗
2026-04-01
Current report 8-K
Exec/director change
Filing ↗
2026-03-11
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2026-03-09
Employee stock plan shares S-8
Filing ↗
2026-03-09
Annual report 10-K
Filing ↗
2026-03-09
Current report 8-K
Earnings results
Filing ↗
2026-02-17
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-01-30
Current report 8-K
Exec/director change
Filing ↗
2026-01-05
Insider trade 4
Filing ↗
2026-01-05
Insider trade 4
Filing ↗
2026-01-05
Insider trade 4
Filing ↗
2026-01-05
Insider trade 4
Filing ↗
2026-01-05
Insider trade 4
Filing ↗
2025-12-11
Insider trade 4
Filing ↗
2025-11-18
5%+ stake update (13D) SCHEDULE 13D/A
Filing ↗
2025-11-18
Planned insider sale 144
Filing ↗